Wuhan Keqian BiologyLtd Management
Management criteria checks 3/4
Wuhan Keqian BiologyLtd's CEO is Mulin Chen, appointed in Jun 2018, has a tenure of 6.5 years. directly owns 0.01% of the company’s shares, worth CN¥694.70K. The average tenure of the management team and the board of directors is 6.5 years and 7.9 years respectively.
Key information
Mulin Chen
Chief executive officer
CN¥1.6m
Total compensation
| CEO salary percentage | n/a |
| CEO tenure | 6.5yrs |
| CEO ownership | 0.01% |
| Management average tenure | 6.5yrs |
| Board average tenure | 7.9yrs |
Recent management updates
Recent updates
CEO
Mulin Chen (36 yo)
6.5yrs
Tenure
CN¥1,591,000
Compensation
Ms. Mulin Chen is General Manager of Wuhan Keqian Biology Co.,Ltd from June 04, 2018 and was its Board Secretary since May 2013 until May 2022. He is Chairman of Wuhan Keqian Biology Co.,Ltd from July 05,...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| GM & Chairman | 6.5yrs | CN¥1.59m | 0.010% CN¥ 694.7k | |
| CFO, Deputy GM | 1.4yrs | CN¥1.59m | 0.010% CN¥ 694.7k | |
| Board Secretary | 2.6yrs | CN¥547.00k | 0.0023% CN¥ 158.5k |
6.5yrs
Average Tenure
41yo
Average Age
Experienced Management: 688526's management team is seasoned and experienced (6.5 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| GM & Chairman | 1.4yrs | CN¥1.59m | 0.010% CN¥ 694.7k | |
| CFO, Deputy GM | 1.4yrs | CN¥1.59m | 0.010% CN¥ 694.7k | |
| Director | 24yrs | no data | 7.14% CN¥ 494.3m | |
| Supervisory Board Chairman | 24yrs | no data | 7.14% CN¥ 494.3m | |
| Director | 14.7yrs | no data | 7.14% CN¥ 494.3m | |
| Supervisor | 24.7yrs | no data | 5.54% CN¥ 383.0m | |
| Independent Director | 4.1yrs | CN¥100.00k | no data | |
| Independent Director | 5.6yrs | CN¥100.00k | no data | |
| Independent Director | 4.1yrs | CN¥100.00k | no data | |
| Director | 10.3yrs | no data | 6.16% CN¥ 425.9m |
7.9yrs
Average Tenure
56.5yo
Average Age
Experienced Board: 688526's board of directors are considered experienced (7.9 years average tenure).
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/27 19:58 |
| End of Day Share Price | 2024/12/27 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Wuhan Keqian Biology Co.,Ltd is covered by 10 analysts. 6 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Xie Zhiyou | China Galaxy Securities Co., Ltd. |
| Junhao Fan | China International Capital Corporation Limited |
| Siyang Wang | China International Capital Corporation Limited |